We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hematology

Image: New assay enables simultaneous determination of total Aβ40 and Aβ42 levels (Photo courtesy of Araclon Biotech)

Unique Diagnostic Test Based on Mass Spectrometry Technique Accurately Identifies Early-Stage Alzheimer's Disease

Cerebral amyloid load is one of the first signs of early-onset Alzheimer's Disease (AD) in individuals with subjective memory complaints (SMCs) and has potential for use as a biomarker to indicate how the condition evolves. A new assay based on mass spectrometry has shown to be capable of quantifying amyloid-beta 40 and 42 proteins – both associated with the risk of having AD – in plasma samples. More...
16 Mar 2022
Image: The secretoneurin ELISA cardiovascular risk test has received CE Mark (Photo courtesy of Unsplash)

ELISA Blood Test Uses Innovative Biomarker to Detect Heart Disease and Sudden Cardiac Arrest

The CardiNor SN assay from Cardinor AS (Oslo, Norway) is a blood-based cardiovascular risk test that detects SN, a small 33-amino acid neuropeptide detectable in the blood stream and produced by neuroendocrine and heart muscle cells. SN is the only biomarker shown to be associated with biological processes linked to cardiomyocyte handling and has been described as the “missing link biomarker” in CVD risk assessment. More...
15 Mar 2022
Image: PyroMark Q96 ID instrument for quantitative analysis of genetic or epigenetic DNA modifications using Pyrosequencing technology (Photo courtesy of Karolinska Institutet)

Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis

Differential leukocyte counts are usually measured based on cellular morphology or surface marker expression. It has recently been shown that leukocyte counts can also be determined by cell-type–specific DNA methylation (DNAm). Such epigenetic leukocyte counting is applicable to small blood volumes and even frozen material, but for clinical translation, the method needs to be further refined and validated. More...
14 Mar 2022
Image: Nova Max Pro Creatinine/eGFR Meter (Photo courtesy of Nova Biomedical)

Nova Biomedical Launches CE-Marked Nova Max Pro Creatinine/eGFR Meter for Kidney Function Screening

Nova Biomedical (Waltham, MA, USA) has launched the Nova Max Pro Creatinine/eGFR Meter System in all CE countries. Nova Max Pro is an important new tool to improve kidney care through kidney function screening and early detection of kidney disease in point-of-care settings outside the hospital. More...
14 Mar 2022
Image: Aza Technology’s rapid ammonia monitoring device (AMD) (Photo courtesy of Aza Technology)

Rapid POC Blood Ammonia Detector Could Dramatically Decrease Processing Times from Hours to Minutes

Aza Technology Inc. has developed a Rapid Ammonia Monitoring Device (AMD) intended for the quantitative determination of ammonia in whole blood, which enables the early detection of hyperammonemia that is critical to prevent irreversible neurological damage, coma, and death. The AMD can be lifesaving as it aims to dramatically decrease blood ammonia processing times from hours to minutes. More...
14 Mar 2022
Image: Blood test could be possible diagnostic tool for Alzheimer’s (Photo courtesy of Unsplash)

Blood Test Can Estimate Presence of Alzheimer’s Disease Changes and Blood Vessel Damage in the Brain

Due to recent technological developments, blood-based biomarkers of disease are now available and researchers from the Sanders-Brown Center on Aging at the University of Kentucky (Lexington, KY, USA) believe they could be beneficial in the diagnosis of Alzheimer’s and other dementias. A biomarker – short for biological marker – is a measurable indicator that captures what is happening in a cell or an organism at a given moment. More...
11 Mar 2022
Image: New risk algorithm to improve screening for prostate cancer (Photo courtesy of University College London)

Algorithm Calculates Risk of Developing Prostate Cancer Using Results from Two Blood Markers

Calculating a person’s risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, according to a new study. More...
09 Mar 2022
New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Blood Glucose Test Strip
AutoSense Test


The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.